KYOWA KIRIN HOLDINGS B.V.

Italy

All drugs from this manufacturer

  • CRYSVITA

    It is used for the treatment of X-linked hypophosphatemia (XLH) in children, adolescents, and adults, and for the treatment of tumor-induced osteomalacia (TIO) in cases where the causative tumor cannot be identified or successfully removed.

    Dosage form: solution for injection

    Active substance Dosage
    burosumab -

    ATC: M05BX05

  • POTELIGEO

    This medicine is used to treat adults with mycosis fungoides and Sézary syndrome, two types of skin cancers called cutaneous T-cell lymphomas, in patients who have already received at least one other treatment by mouth or by injection.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    mogamulizumab -

    ATC: L01FX09